Edition:
United States

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

8.61USD
16 Feb 2018
Change (% chg)

$-0.20 (-2.27%)
Prev Close
$8.81
Open
$8.66
Day's High
$8.67
Day's Low
$8.61
Volume
1,391
Avg. Vol
5,120
52-wk High
$11.98
52-wk Low
$8.03

Latest Key Developments (Source: Significant Developments)

Krystal Biotech reports qtrly loss per share $1.26‍​
Monday, 13 Nov 2017 04:01pm EST 

Nov 13 (Reuters) - Krystal Biotech Inc :Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results.Krystal Biotech Inc qtrly loss per share $1.26‍​.Krystal Biotech Inc - ‍Currently preparing to file an investigational drug application for KB103 in Q1 of 2018​.  Full Article

Krystal Biotech says KB103 granted orphan drug designation by FDA
Tuesday, 7 Nov 2017 08:00am EST 

Nov 7 (Reuters) - Krystal Biotech Inc :Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa.Krystal Biotech Inc - on track to file IND for KB103 in Q1 2018​.  Full Article

Krystal Biotech shares open at 5 pct above IPO price
Wednesday, 20 Sep 2017 12:16pm EDT 

Sept 20 (Reuters) - :Krystal Biotech Inc shares open at $10.50 in debut on the NASDAQ versus IPO price of $10.00 per share.  Full Article

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results